207 related articles for article (PubMed ID: 6429243)
21. CCR3, CCR5, interleukin 4, and interferon-gamma expression on synovial and peripheral T cells and monocytes in patients with rheumatoid arthritis.
Nissinen R; Leirisalo-Repo M; Tiittanen M; Julkunen H; Hirvonen H; Palosuo T; Vaarala O
J Rheumatol; 2003 Sep; 30(9):1928-34. PubMed ID: 12966592
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of IL-15 in the synovium of patients with rheumatoid arthritis compared with patients with Yersinia-induced arthritis and osteoarthritis.
Thurkow EW; van der Heijden IM; Breedveld FC; Smeets TJ; Daha MR; Kluin PM; Meinders AE; Tak PP
J Pathol; 1997 Apr; 181(4):444-50. PubMed ID: 9196444
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the natural killer-like lymphocytes in rheumatoid synovial fluid.
Goto M; Zvaifler NJ
J Immunol; 1985 Mar; 134(3):1483-6. PubMed ID: 3968425
[TBL] [Abstract][Full Text] [Related]
24. Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis.
van Amelsfort JM; van Roon JA; Noordegraaf M; Jacobs KM; Bijlsma JW; Lafeber FP; Taams LS
Arthritis Rheum; 2007 Mar; 56(3):732-42. PubMed ID: 17328044
[TBL] [Abstract][Full Text] [Related]
25. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.
Yudoh K; Matsuno H; Nakazawa F; Yonezawa T; Kimura T
Arthritis Rheum; 2000 Mar; 43(3):617-27. PubMed ID: 10728756
[TBL] [Abstract][Full Text] [Related]
26. Increased intraarticular interleukin-7 in rheumatoid arthritis patients stimulates cell contact-dependent activation of CD4(+) T cells and macrophages.
van Roon JA; Verweij MC; Wijk MW; Jacobs KM; Bijlsma JW; Lafeber FP
Arthritis Rheum; 2005 Jun; 52(6):1700-10. PubMed ID: 15934068
[TBL] [Abstract][Full Text] [Related]
27. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid.
van Amelsfort JM; Jacobs KM; Bijlsma JW; Lafeber FP; Taams LS
Arthritis Rheum; 2004 Sep; 50(9):2775-85. PubMed ID: 15457445
[TBL] [Abstract][Full Text] [Related]
28. Impaired natural killing activity in patients with rheumatoid arthritis. Clinical characteristics and a study of defective mechanisms.
Fantini F; Valenti F; Mercuriali F; Marin F; Panajotopoulos N
Boll Ist Sieroter Milan; 1986; 65(1):40-6. PubMed ID: 3487336
[TBL] [Abstract][Full Text] [Related]
29. Regulation of interleukin-18 binding protein production by blood and synovial cells from patients with rheumatoid arthritis.
Kawashima M; Novick D; Rubinstein M; Miossec P
Arthritis Rheum; 2004 Jun; 50(6):1800-5. PubMed ID: 15188356
[TBL] [Abstract][Full Text] [Related]
30. Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis.
Yamamura M; Kawashima M; Taniai M; Yamauchi H; Tanimoto T; Kurimoto M; Morita Y; Ohmoto Y; Makino H
Arthritis Rheum; 2001 Feb; 44(2):275-85. PubMed ID: 11229457
[TBL] [Abstract][Full Text] [Related]
31. Rheumatoid arthritis synovial fluid macrophages express decreased tumor necrosis factor-related apoptosis-inducing ligand R2 and increased decoy receptor tumor necrosis factor-related apoptosis-inducing ligand R3.
Perlman H; Nguyen N; Liu H; Eslick J; Esser S; Walsh K; Moore TL; Pope RM
Arthritis Rheum; 2003 Nov; 48(11):3096-101. PubMed ID: 14613271
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic activity of rheumatoid and normal lymphocytes against allogeneic and autologous synovial cells in vitro.
Griffiths MM; Smith CB; Ward JR; Klauber MR
J Clin Invest; 1976 Sep; 58(3):613-22. PubMed ID: 956390
[TBL] [Abstract][Full Text] [Related]
33. Resistance of rheumatoid synovial dendritic cells to the immunosuppressive effects of IL-10.
MacDonald KP; Pettit AR; Quinn C; Thomas GJ; Thomas R
J Immunol; 1999 Nov; 163(10):5599-607. PubMed ID: 10553089
[TBL] [Abstract][Full Text] [Related]
34. Phenotypic and functional characterization of peripheral blood and bone marrow natural killer cells prior to autologous transplantation.
Arbour S; Toupin S; Bélanger R; Gyger M; Hallé JP; Perreault C; Roy DC
Bone Marrow Transplant; 1996 Mar; 17(3):315-22. PubMed ID: 8704680
[TBL] [Abstract][Full Text] [Related]
35. Interleukin 16 expression in relation to disease activity in rheumatoid arthritis.
Blaschke S; Schulz H; Schwarz G; Blaschke V; Müller GA; Reuss-Borst M
J Rheumatol; 2001 Jan; 28(1):12-21. PubMed ID: 11196512
[TBL] [Abstract][Full Text] [Related]
36. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption.
Laso FJ; Madruga JI; Girón JA; López A; Ciudad J; San Miguel JF; Alvarez-Mon M; Orfao A
Hepatology; 1997 May; 25(5):1096-100. PubMed ID: 9141423
[TBL] [Abstract][Full Text] [Related]
37. A comparison of lymphocyte subpopulations simultaneously on local and systemic levels in acute rheumatoid arthritis patients.
Ravlić-Gulan J; Gulan G; Novak S; Duletić-Nacinović A; Matovinović D; Rukavina D
Coll Antropol; 2005 Dec; 29(2):661-9. PubMed ID: 16417179
[TBL] [Abstract][Full Text] [Related]
38. Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production.
Zhu P; Ding J; Zhou J; Dong WJ; Fan CM; Chen ZN
Arthritis Res Ther; 2005; 7(5):R1023-33. PubMed ID: 16207318
[TBL] [Abstract][Full Text] [Related]
39. Functional analysis of rheumatoid factor-producing B cells from the synovial fluid of rheumatoid arthritis patients.
Reparon-Schuijt CC; van Esch WJ; van Kooten C; Levarht EW; Breedveld FC; Verweij CL
Arthritis Rheum; 1998 Dec; 41(12):2211-20. PubMed ID: 9870878
[TBL] [Abstract][Full Text] [Related]
40. Increase of soluble FcgRIIIa derived from natural killer cells and macrophages in plasma from patients with rheumatoid arthritis.
Masuda M; Morimoto T; De Haas M; Nishimura N; Nakamoto K; Okuda K; Komiyama Y; Ogawa R; Takahashi H
J Rheumatol; 2003 Sep; 30(9):1911-7. PubMed ID: 12966590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
